How Secretory IgA Reflects Intestinal Mucosal Barrier Function

The intestinal mucosa serves as a critical barrier between the body and the external environment. It’s constantly exposed to a myriad of potential threats, including pathogens, toxins, and allergens. A key player in maintaining this barrier is secretory IgA (sIgA), an immunoglobulin that plays a vital role in mucosal immune function. By investigating sIgA levels, researchers can gain valuable insights into the health and integrity of the intestinal mucosa.

What is Secretory IgA (sIgA)?

Secretory IgA (sIgA) is an immunoglobulin found on mucosal surfaces that plays a critical role in protecting the intestinal barrier by neutralizing pathogens, toxins, and antigens before they penetrate the gut lining.

sIgA is produced by plasma cells in the lamina propria and is secreted into the intestinal lumen. It forms a protective layer on mucosal surfaces, acting as the first line of defense against harmful substances. Unlike serum IgA, secretory IgA is more stable due to its unique structure, making it a reliable biomarker to assess intestinal mucosal integrity.

Because of its stability and direct interaction with the mucosal surface, sIgA is widely used as a biomarker to investigate intestinal mucosal integrity and immune function.

Why Measure Secretory IgA in Stool?

Measuring sIgA concentrations in stool helps researchers:

  • Evaluate Intestinal Immune Function: Low sIgA levels may indicate a weakened intestinal immune system, increasing susceptibility to infections and other gastrointestinal issues. Conversely, elevated levels may suggest heightened immune activity or local inflammation.
  • Identify Potential Immunodeficiencies: Reduced or absent sIgA can indicate immunodeficiencies, affecting overall health and well-being.
  • Observe Stress and Nutrient Intake: Changes in sIgA levels can be associated with physical and mental stress and nutrient deficiencies.
  • Investigate Gastrointestinal Disorders: Abnormal sIgA levels may be indicative of various gastrointestinal disorders, including inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and celiac disease.

How the IDK® Secretory IgA ELISA Supports sIgA Measurement in Stool and Saliva

The IDK® sIgA ELISA is intended for the quantitative determination of secretory IgA (sIgA) in saliva and stool, helping investigators efficiently assess intestinal mucosal immune function. The test offers several advantages, including:

  • Simplified Stool Sample Preparation: When paired with the IDK Extract® Stool Collection Tubes.
  • Optimized for High-Throughput Workflows: Automation possible – contact us to discover more!
  • Small Sample Volume Required: Only 15 mg of stool or 10 µL of saliva is required, enabling flexible procedures.

Frequently Asked Questions About Secretory IgA

What does low secretory IgA indicate?

Low sIgA levels may indicate weakened mucosal immunity, increased susceptibility to infection, or immune dysregulation.

What does high secretory IgA mean?

Elevated sIgA levels can reflect immune activation in response to infection, inflammation, or antigen exposure.

Is secretory IgA different from serum IgA?

Yes. Secretory IgA is structurally distinct and more stable than serum IgA, making it better suited for studying mucosal immune function.

Secretory IgA: An Indicator of Intestinal Mucosal Barrier Health

Secretory IgA is a critical indicator of intestinal mucosal barrier health and immune function. By investigating sIgA levels, researchers can gain valuable insights into the health and function of the intestinal immune system. This information can aid in the identification, management, and prevention of various gastrointestinal disorders.

References

  1. Strugnell RA et al. (2010) The role of secretory antibodies in infection immunity. Nat Rev Microbiol 8(9):656–667. PMID: 20694027.
  2. Mohan R et al. (2008) Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotec­tin, and IgA in preterm infants. Pediatr Res 64(4):418-22. PMID: 18552710.
  3. Michalsen A et al. (2005) Mediterranean diet or extended fasting‘s influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study. BMC Complement Altern Med 5:22. PMID: 16372904.
  4. Brandtzaeg P (1981) Transport models for secretory IgA and secretory IgM. Clin Exp Immunol 44(2):221-231. PMID: 6118214.

 

The IDK® sIgA ELISA is For Research Use Only. Not For Use in Diagnostic Procedures.

For Lab Professional Use Only.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Share it!

Become an IDK Insider!

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors